These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Development and evaluation of colloidal modified nanolipid carrier: application to topical delivery of tacrolimus, Part II--in vivo assessment, drug targeting, efficacy, and safety in treatment for atopic dermatitis. Pople PV; Singh KK Eur J Pharm Biopharm; 2013 May; 84(1):72-83. PubMed ID: 23246619 [TBL] [Abstract][Full Text] [Related]
4. In vivo skin penetration of macromolecules in irritant contact dermatitis. Abdel-Mottaleb MMA; Lamprecht A Int J Pharm; 2016 Dec; 515(1-2):384-389. PubMed ID: 27771484 [TBL] [Abstract][Full Text] [Related]
6. Is the Fractional Laser Still Effective in Assisting Cutaneous Macromolecule Delivery in Barrier-Deficient Skin? Psoriasis and Atopic Dermatitis as the Disease Models. Lee WR; Shen SC; Sung CT; Liu PY; Fang JY Pharm Res; 2018 Apr; 35(7):128. PubMed ID: 29700662 [TBL] [Abstract][Full Text] [Related]
7. Polymeric micelle nanocarriers for the cutaneous delivery of tacrolimus: a targeted approach for the treatment of psoriasis. Lapteva M; Mondon K; Möller M; Gurny R; Kalia YN Mol Pharm; 2014 Sep; 11(9):2989-3001. PubMed ID: 25057896 [TBL] [Abstract][Full Text] [Related]
8. Penetration of topically applied nanocarriers into the hair follicles of dog and rat dorsal skin and porcine ear skin. Knorr F; Patzelt A; Darvin ME; Lehr CM; Schäfer U; Gruber AD; Ostrowski A; Lademann J Vet Dermatol; 2016 Aug; 27(4):256-e60. PubMed ID: 27229377 [TBL] [Abstract][Full Text] [Related]
9. In-vivo dermal pharmacokinetics, efficacy, and safety of skin targeting nanoparticles for corticosteroid treatment of atopic dermatitis. Siddique MI; Katas H; Amin MC; Ng SF; Zulfakar MH; Jamil A Int J Pharm; 2016 Jun; 507(1-2):72-82. PubMed ID: 27154252 [TBL] [Abstract][Full Text] [Related]
10. Innovative drug vehicle for local treatment of inflammatory skin diseases: Ex vivo and in vivo screening of five topical formulations containing poly(lactic acid) (PLA) nanoparticles. Boisgard AS; Lamrayah M; Dzikowski M; Salmon D; Kirilov P; Primard C; Pirot F; Fromy B; Verrier B Eur J Pharm Biopharm; 2017 Jul; 116():51-60. PubMed ID: 27702687 [TBL] [Abstract][Full Text] [Related]
12. Targeted cutaneous delivery of ciclosporin A using micellar nanocarriers and the possible role of inter-cluster regions as molecular transport pathways. Lapteva M; Santer V; Mondon K; Patmanidis I; Chiriano G; Scapozza L; Gurny R; Möller M; Kalia YN J Control Release; 2014 Dec; 196():9-18. PubMed ID: 25278258 [TBL] [Abstract][Full Text] [Related]
13. Targeting tacrolimus to deeper layers of skin with improved safety for treatment of atopic dermatitis. Pople PV; Singh KK Int J Pharm; 2010 Oct; 398(1-2):165-78. PubMed ID: 20637847 [TBL] [Abstract][Full Text] [Related]
14. Localization of dexamethasone within dendritic core-multishell (CMS) nanoparticles and skin penetration properties studied by multi-frequency electron paramagnetic resonance (EPR) spectroscopy. Saeidpour S; Lohan SB; Anske M; Unbehauen M; Fleige E; Haag R; Meinke MC; Bittl R; Teutloff C Eur J Pharm Biopharm; 2017 Jul; 116():94-101. PubMed ID: 27756683 [TBL] [Abstract][Full Text] [Related]
15. Self-assembled polymeric nanoparticles for percutaneous co-delivery of hydrocortisone/hydroxytyrosol: an ex vivo and in vivo study using an NC/Nga mouse model. Hussain Z; Katas H; Mohd Amin MC; Kumolosasi E; Buang F; Sahudin S Int J Pharm; 2013 Feb; 444(1-2):109-19. PubMed ID: 23337632 [TBL] [Abstract][Full Text] [Related]
16. Comparison of PLGA and lecithin/chitosan nanoparticles for dermal targeting of betamethasone valerate. Özcan I; Azizoğlu E; Senyiğit T; Özyazici M; Özer Ö J Drug Target; 2013 Jul; 21(6):542-50. PubMed ID: 23390922 [TBL] [Abstract][Full Text] [Related]
17. Targeting tacrolimus to deeper layers of skin with improved safety for treatment of atopic dermatitis-Part II: in vivo assessment of dermatopharmacokinetics, biodistribution and efficacy. Pople PV; Singh KK Int J Pharm; 2012 Sep; 434(1-2):70-9. PubMed ID: 22609427 [TBL] [Abstract][Full Text] [Related]
18. Skin barrier disruptions in tape stripped and allergic dermatitis models have no effect on dermal penetration and systemic distribution of AHAPS-functionalized silica nanoparticles. Ostrowski A; Nordmeyer D; Boreham A; Brodwolf R; Mundhenk L; Fluhr JW; Lademann J; Graf C; Rühl E; Alexiev U; Gruber AD Nanomedicine; 2014 Oct; 10(7):1571-81. PubMed ID: 24768631 [TBL] [Abstract][Full Text] [Related]
19. A new concept for the treatment of atopic dermatitis: silver-nanolipid complex (sNLC). Keck CM; Anantaworasakul P; Patel M; Okonogi S; Singh KK; Roessner D; Scherrers R; Schwabe K; Rimpler C; Müller RH Int J Pharm; 2014 Feb; 462(1-2):44-51. PubMed ID: 24378329 [TBL] [Abstract][Full Text] [Related]